Toplexil Syrup

Toplexil is a cough syrup primarily used to alleviate dry and irritating coughs, especially those occurring at night. It contains oxomemazine, an antihistamine with antitussive and sedative properties, and guaifenesin, an expectorant. The product is manufactured in multiple countries, including France, Belgium, Luxembourg, the Netherlands, Tunisia, Indonesia, Kuwait, and Lebanon. Sanofi-Aventis, the original company behind Toplexil, is a subsidiary of Sanofi, a global biopharmaceutical company headquartered in France. The brand is marketed in various countries, including France, Belgium, Luxembourg, the Netherlands, Tunisia, Indonesia, Kuwait, and Lebanon. In the United States, Toplexil is not approved by the FDA and is not available for sale. The product is intended for adults and children over 2 years of age, with dosage varying based on age and weight. Common side effects may include drowsiness, dry mouth, and dizziness. Users are advised to avoid driving or operating heavy machinery after taking the medication due to its sedative effects.